31.05.2014 | GlaxoSmithKline is facing more than double jeopardy
In an article published in The Telegraph, Alaco's Jonathan Russell asks whether double jeopardy may come to be a factor in international fraud or bribery investigations.
Read the full article here
Next >
< Prev